Ad is loading...
ABUS
Price
$3.64
Change
+$0.01 (+0.28%)
Updated
Nov 15 closing price
102 days until earnings call
HOTH
Price
$0.82
Change
-$0.03 (-3.53%)
Updated
Nov 15 closing price
Ad is loading...

ABUS vs HOTH

Header iconABUS vs HOTH Comparison
Open Charts ABUS vs HOTHBanner chart's image
Arbutus Biopharma
Price$3.64
Change+$0.01 (+0.28%)
Volume$1.79M
CapitalizationN/A
Hoth Therapeutics
Price$0.82
Change-$0.03 (-3.53%)
Volume$157.75K
CapitalizationN/A
ABUS vs HOTH Comparison Chart
Loading...
ABUS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
HOTH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ABUS vs. HOTH commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABUS is a StrongSell and HOTH is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (ABUS: $3.64 vs. HOTH: $0.82)
Brand notoriety: ABUS and HOTH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABUS: 166% vs. HOTH: 15%
Market capitalization -- ABUS: $689.75M vs. HOTH: $5.65M
ABUS [@Biotechnology] is valued at $689.75M. HOTH’s [@Biotechnology] market capitalization is $5.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABUS’s FA Score shows that 0 FA rating(s) are green whileHOTH’s FA Score has 1 green FA rating(s).

  • ABUS’s FA Score: 0 green, 5 red.
  • HOTH’s FA Score: 1 green, 4 red.
According to our system of comparison, ABUS is a better buy in the long-term than HOTH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABUS’s TA Score shows that 2 TA indicator(s) are bullish while HOTH’s TA Score has 3 bullish TA indicator(s).

  • ABUS’s TA Score: 2 bullish, 6 bearish.
  • HOTH’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, HOTH is a better buy in the short-term than ABUS.

Price Growth

ABUS (@Biotechnology) experienced а -2.93% price change this week, while HOTH (@Biotechnology) price change was -10.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

ABUS is expected to report earnings on Feb 27, 2025.

HOTH is expected to report earnings on Mar 01, 2023.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABUS($690M) has a higher market cap than HOTH($5.65M). ABUS YTD gains are higher at: 45.600 vs. HOTH (-43.188). HOTH has higher annual earnings (EBITDA): -7.49M vs. ABUS (-75.48M). ABUS has more cash in the bank: 142M vs. HOTH (9.66M). HOTH has less debt than ABUS: HOTH (41.1K) vs ABUS (1.6M). ABUS has higher revenues than HOTH: ABUS (10.1M) vs HOTH (0).
ABUSHOTHABUS / HOTH
Capitalization690M5.65M12,217%
EBITDA-75.48M-7.49M1,008%
Gain YTD45.600-43.188-106%
P/E RatioN/AN/A-
Revenue10.1M0-
Total Cash142M9.66M1,471%
Total Debt1.6M41.1K3,886%
FUNDAMENTALS RATINGS
ABUS: Fundamental Ratings
ABUS
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
49
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABUSHOTH
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
78%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 7 days ago
89%
Aroon
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Ad is loading...
ABUS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
HOTH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICFAX11.160.03
+0.27%
ICON Consumer Select Investor
HWACX37.33-0.22
-0.59%
Hotchkis & Wiley Value Opps C
HNLVX24.03-0.21
-0.87%
Harbor Large Cap Value Retirement
VTSIX98.12-0.90
-0.91%
Vanguard Tax-Managed Small Cap I
DFSGX25.49-0.36
-1.39%
DF Dent Small Cap Growth Institutional

ABUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABUS has been loosely correlated with ARRY. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ABUS jumps, then ARRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABUS
1D Price
Change %
ABUS100%
+0.28%
ARRY - ABUS
43%
Loosely correlated
-10.22%
AXON - ABUS
42%
Loosely correlated
-0.86%
ROIV - ABUS
41%
Loosely correlated
-3.78%
VCYT - ABUS
38%
Loosely correlated
-2.97%
VIR - ABUS
38%
Loosely correlated
-7.29%
More

HOTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOTH has been loosely correlated with TIL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if HOTH jumps, then TIL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOTH
1D Price
Change %
HOTH100%
-3.24%
TIL - HOTH
34%
Loosely correlated
-9.99%
PPTDF - HOTH
32%
Poorly correlated
N/A
AIM - HOTH
30%
Poorly correlated
-11.75%
OGEN - HOTH
28%
Poorly correlated
-2.49%
ABUS - HOTH
27%
Poorly correlated
+0.28%
More